Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Expression of functional folate receptors in multiple myeloma.

Zhou Y, Unno K, Hyjek E, Liu H, Zimmerman T, Karmakar S, Putt KS, Shen J, Low PS, Wickrema A.

Leuk Lymphoma. 2018 Apr 4:1-8. doi: 10.1080/10428194.2018.1453066. [Epub ahead of print]

PMID:
29616859
2.

Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype.

Gołąb K, Grose R, Placencia V, Wickrema A, Solomina J, Tibudan M, Konsur E, Ciepły K, Marek-Trzonkowska N, Trzonkowski P, Millis JM, Fung J, Witkowski P.

Oncotarget. 2018 Jan 3;9(11):9728-9740. doi: 10.18632/oncotarget.23887. eCollection 2018 Feb 9.

3.

Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.

Tsai SB, Rhodes J, Liu H, Shore T, Bishop M, Cushing MM, Gergis U, Godley L, Kline J, Larson RA, Mayer S, Odenike O, Stock W, Wickrema A, van Besien K, Artz AS.

Biol Blood Marrow Transplant. 2018 May;24(5):997-1004. doi: 10.1016/j.bbmt.2017.12.794. Epub 2017 Dec 27.

PMID:
29288821
4.

Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation.

Bhagat TD, Chen S, Bartenstein M, Barlowe AT, Von Ahrens D, Choudhary GS, Tivnan P, Amin E, Marcondes AM, Sanders MA, Hoogenboezem RM, Kambhampati S, Ramachandra N, Mantzaris I, Sukrithan V, Laurence R, Lopez R, Bhagat P, Giricz O, Sohal D, Wickrema A, Yeung C, Gritsman K, Aplan P, Hochedlinger K, Yu Y, Pradhan K, Zhang J, Greally JM, Mukherjee S, Pellagatti A, Boultwood J, Will B, Steidl U, Raaijmakers MHGP, Deeg HJ, Kharas MG, Verma A.

Cancer Res. 2017 Sep 15;77(18):4846-4857. doi: 10.1158/0008-5472.CAN-17-0282. Epub 2017 Jul 6.

PMID:
28684528
5.

Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis.

Gilles L, Arslan AD, Marinaccio C, Wen QJ, Arya P, McNulty M, Yang Q, Zhao JC, Konstantinoff K, Lasho T, Pardanani A, Stein B, Plo I, Sundaravel S, Wickrema A, Migliaccio A, Gurbuxani S, Vainchenker W, Platanias LC, Tefferi A, Crispino JD.

J Clin Invest. 2017 Apr 3;127(4):1316-1320. doi: 10.1172/JCI82905. Epub 2017 Feb 27.

6.

Utilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders.

Gołąb K, Grose R, Trzonkowski P, Wickrema A, Tibudan M, Marek-Trzonkowska N, Matosz S, Solomina J, Ostrega D, Michael Millis J, Witkowski P.

Oncotarget. 2016 Nov 29;7(48):79474-79484. doi: 10.18632/oncotarget.13101.

7.

The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes.

Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V, Lazarus HM, Litzow M, Loren A, Majhail NS, Maziarz RT, McCarthy P, Popat U, Saber W, Spellman S, Ringden O, Wickrema A, Pasquini MC, Cooke KR; from the Center for International Blood and Marrow Transplantation Research.

Haematologica. 2016 Nov;101(11):1426-1433. Epub 2016 Aug 4.

8.

Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy.

Rojek K, Nickels E, Neistadt B, Marquez R, Wickrema A, Artz A, van Besien K, Larson RA, Lee MK, Segal JP, King MC, Walsh T, Shimamura A, Keel SB, Churpek JE, Godley LA.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2100-2103. doi: 10.1016/j.bbmt.2016.08.002. Epub 2016 Aug 4.

9.

Nuclear Condensation during Mouse Erythropoiesis Requires Caspase-3-Mediated Nuclear Opening.

Zhao B, Mei Y, Schipma MJ, Roth EW, Bleher R, Rappoport JZ, Wickrema A, Yang J, Ji P.

Dev Cell. 2016 Mar 7;36(5):498-510. doi: 10.1016/j.devcel.2016.02.001.

10.

Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.

Tsai SB, Liu H, Shore T, Fan Y, Bishop M, Cushing MM, Gergis U, Godley L, Kline J, Larson RA, Martinez G, Mayer S, Odenike O, Stock W, Wickrema A, van Besien K, Artz AS.

Biol Blood Marrow Transplant. 2016 Jun;22(6):1065-1072. doi: 10.1016/j.bbmt.2016.02.010. Epub 2016 Feb 19.

11.

Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.

van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, Cushing MM, Korman S, Artz A.

Haematologica. 2016 May;101(5):634-43. doi: 10.3324/haematol.2015.138594. Epub 2016 Feb 11.

12.

Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.

Sundaravel S, Duggan R, Bhagat T, Ebenezer DL, Liu H, Yu Y, Bartenstein M, Unnikrishnan M, Karmakar S, Liu TC, Torregroza I, Quenon T, Anastasi J, McGraw KL, Pellagatti A, Boultwood J, Yajnik V, Artz A, Le Beau MM, Steidl U, List AF, Evans T, Verma A, Wickrema A.

Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):E6359-68. doi: 10.1073/pnas.1516394112. Epub 2015 Nov 2.

13.

Ineffective erythropoiesis caused by binucleated late-stage erythroblasts in mDia2 hematopoietic specific knockout mice.

Mei Y, Zhao B, Yang J, Gao J, Wickrema A, Wang D, Chen Y, Ji P.

Haematologica. 2016 Jan;101(1):e1-5. doi: 10.3324/haematol.2015.134221. Epub 2015 Oct 15. No abstract available.

14.

Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.

Yew PY, Alachkar H, Yamaguchi R, Kiyotani K, Fang H, Yap KL, Liu HT, Wickrema A, Artz A, van Besien K, Imoto S, Miyano S, Bishop MR, Stock W, Nakamura Y.

Bone Marrow Transplant. 2015 Sep;50(9):1227-34. doi: 10.1038/bmt.2015.133. Epub 2015 Jun 8.

15.

IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.

Schinke C, Giricz O, Li W, Shastri A, Gordon S, Barreyro L, Bhagat T, Bhattacharyya S, Ramachandra N, Bartenstein M, Pellagatti A, Boultwood J, Wickrema A, Yu Y, Will B, Wei S, Steidl U, Verma A.

Blood. 2015 May 14;125(20):3144-52. doi: 10.1182/blood-2015-01-621631. Epub 2015 Mar 25. Erratum in: Blood. 2015 Jul 16;126(3):425. Barreryo, Laura [corrected to Barreyro, Laura].

16.

Unexplained anaemia in the elderly is characterised by features of low grade inflammation.

Artz AS, Xue QL, Wickrema A, Hesdorffer C, Ferrucci L, Langdon JM, Walston JD, Roy CN.

Br J Haematol. 2014 Oct;167(2):286-9. doi: 10.1111/bjh.12984. Epub 2014 Jun 17. No abstract available.

17.

Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant.

Petri CR, O'Donnell PH, Cao H, Artz AS, Stock W, Wickrema A, Hard M, van Besien K.

Leuk Lymphoma. 2014 Dec;55(12):2866-73. doi: 10.3109/10428194.2014.897701. Epub 2014 May 27.

18.

Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis.

Madzo J, Liu H, Rodriguez A, Vasanthakumar A, Sundaravel S, Caces DBD, Looney TJ, Zhang L, Lepore JB, Macrae T, Duszynski R, Shih AH, Song CX, Yu M, Yu Y, Grossman R, Raumann B, Verma A, He C, Levine RL, Lavelle D, Lahn BT, Wickrema A, Godley LA.

Cell Rep. 2014 Jan 16;6(1):231-244. doi: 10.1016/j.celrep.2013.11.044. Epub 2013 Dec 27.

19.

Tropomodulin3-null mice are embryonic lethal with anemia due to impaired erythroid terminal differentiation in the fetal liver.

Sui Z, Nowak RB, Bacconi A, Kim NE, Liu H, Li J, Wickrema A, An XL, Fowler VM.

Blood. 2014 Jan 30;123(5):758-67. doi: 10.1182/blood-2013-03-492710. Epub 2013 Oct 24.

20.

Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors.

Mehrotra S, Sharma B, Joshi S, Kroczynska B, Majchrzak B, Stein BL, McMahon B, Altman JK, Licht JD, Baker DP, Eklund EA, Wickrema A, Verma A, Fish EN, Platanias LC.

J Biol Chem. 2013 Aug 16;288(33):23814-22. doi: 10.1074/jbc.M113.476192. Epub 2013 Jun 28.

21.

High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis.

Yu Y, Mo Y, Ebenezer D, Bhattacharyya S, Liu H, Sundaravel S, Giricz O, Wontakal S, Cartier J, Caces B, Artz A, Nischal S, Bhagat T, Bathon K, Maqbool S, Gligich O, Suzuki M, Steidl U, Godley L, Skoultchi A, Greally J, Wickrema A, Verma A.

J Biol Chem. 2013 Mar 29;288(13):8805-14. doi: 10.1074/jbc.M112.423756. Epub 2013 Jan 10.

22.

Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia.

Churpek JE, Nickels E, Marquez R, Rojek K, Liu B, Lorenz R, Lepore J, Madzo J, Wickrema A, Artz AS, van Besien K, Godley LA.

Blood. 2012 Dec 20;120(26):5247-9. doi: 10.1182/blood-2012-09-457945. No abstract available.

23.

Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitors.

Geslain R, Uddin S, Liu H, Jiang H, van Besien K, Pan T, Wickrema A.

Cytokine. 2013 Jan;61(1):329-35. doi: 10.1016/j.cyto.2012.10.017. Epub 2012 Nov 11.

PMID:
23148990
24.

Immune reconstitution after combined haploidentical and umbilical cord blood transplant.

Jain N, Liu H, Artz AS, Anastasi J, Odenike O, Godley LA, Joseph L, Marino S, Kline J, Nguyen V, Schouten V, Kunnavakkam R, Larson RA, Stock W, Ulaszek J, Savage PA, Wickrema A, van Besien K.

Leuk Lymphoma. 2013 Jun;54(6):1242-9. doi: 10.3109/10428194.2012.739688. Epub 2013 Mar 1.

PMID:
23088744
25.

NF-Y recruits both transcription activator and repressor to modulate tissue- and developmental stage-specific expression of human γ-globin gene.

Zhu X, Wang Y, Pi W, Liu H, Wickrema A, Tuan D.

PLoS One. 2012;7(10):e47175. doi: 10.1371/journal.pone.0047175. Epub 2012 Oct 10.

26.

Influence of related donor age on outcomes after peripheral blood stem cell transplantation.

Richa EM, Kunnavakkam R, Godley LA, Kline J, Odenike O, Larson RA, Nguyen V, Stock W, Wickrema A, Van Besien K, Artz AS.

Cytotherapy. 2012 Jul;14(6):707-15. doi: 10.3109/14653249.2012.681041. Epub 2012 May 2.

PMID:
22548695
27.

A novel role for survivin in erythroblast enucleation.

Keerthivasan G, Liu H, Gump JM, Dowdy SF, Wickrema A, Crispino JD.

Haematologica. 2012 Oct;97(10):1471-9. doi: 10.3324/haematol.2011.061093. Epub 2012 Apr 4.

28.

Erythroblast enucleation.

Keerthivasan G, Wickrema A, Crispino JD.

Stem Cells Int. 2011;2011:139851. doi: 10.4061/2011/139851. Epub 2011 Oct 5.

29.

Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.

Liu H, Rich ES, Godley L, Odenike O, Joseph L, Marino S, Kline J, Nguyen V, Cunningham J, Larson RA, del Cerro P, Schroeder L, Pape L, Stock W, Wickrema A, Artz AS, van Besien K.

Blood. 2011 Dec 8;118(24):6438-45. doi: 10.1182/blood-2011-08-372508. Epub 2011 Oct 5.

30.

Will cord blood stem cells come to the rescue of keratinocyte growth factor?

Wickrema A.

Leuk Lymphoma. 2011 Aug;52(8):1423-4. doi: 10.3109/10428194.2011.587563. No abstract available.

PMID:
21756065
31.

P. falciparum modulates erythroblast cell gene expression in signaling and erythrocyte production pathways.

Tamez PA, Liu H, Wickrema A, Haldar K.

PLoS One. 2011 May 4;6(5):e19307. doi: 10.1371/journal.pone.0019307.

32.

Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q.

Zhou L, Opalinska J, Sohal D, Yu Y, Mo Y, Bhagat T, Abdel-Wahab O, Fazzari M, Figueroa M, Alencar C, Zhang J, Kambhampati S, Parmar S, Nischal S, Hueck C, Suzuki M, Freidman E, Pellagatti A, Boultwood J, Steidl U, Sauthararajah Y, Yajnik V, McMahon C, Gore SD, Platanias LC, Levine R, Melnick A, Wickrema A, Greally JM, Verma A.

J Biol Chem. 2011 Jul 15;286(28):25211-23. doi: 10.1074/jbc.M111.235028. Epub 2011 Apr 30.

33.

Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.

Zhou L, McMahon C, Bhagat T, Alencar C, Yu Y, Fazzari M, Sohal D, Heuck C, Gundabolu K, Ng C, Mo Y, Shen W, Wickrema A, Kong G, Friedman E, Sokol L, Mantzaris I, Pellagatti A, Boultwood J, Platanias LC, Steidl U, Yan L, Yingling JM, Lahn MM, List A, Bitzer M, Verma A.

Cancer Res. 2011 Feb 1;71(3):955-63. doi: 10.1158/0008-5472.CAN-10-2933. Epub 2010 Dec 28. Erratum in: Cancer Res. 2011 Apr 1;71(7):2806. Mantzaris, Giannis [corrected to Mantzaris, Ioannis].

34.

Vesicle trafficking plays a novel role in erythroblast enucleation.

Keerthivasan G, Small S, Liu H, Wickrema A, Crispino JD.

Blood. 2010 Oct 28;116(17):3331-40. doi: 10.1182/blood-2010-03-277426. Epub 2010 Jul 19.

35.

Analysis of the kinetics of band 3 diffusion in human erythroblasts during assembly of the erythrocyte membrane skeleton.

Kodippili GC, Spector J, Kang GE, Liu H, Wickrema A, Ritchie K, Low PS.

Br J Haematol. 2010 Sep;150(5):592-600. doi: 10.1111/j.1365-2141.2010.08268.x. Epub 2010 Jun 10.

36.

Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma.

Unno K, Zhou Y, Zimmerman T, Platanias LC, Wickrema A.

Leuk Lymphoma. 2009 Nov;50(11):1865-71. doi: 10.3109/10428190903221010.

37.

Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization.

Richa E, Papari M, Allen J, Martinez G, Wickrema A, Anastasi J, Van Besien K, Artz A.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1394-9. doi: 10.1016/j.bbmt.2009.07.005. Epub 2009 Sep 8.

38.

Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.

van Besien K, Dew A, Lin S, Joseph L, Godley LA, Larson RA, Odenike T, Rich E, Stock W, Wickrema A, Artz AS.

Leuk Lymphoma. 2009 Nov;50(11):1809-17. doi: 10.3109/10428190903200790.

PMID:
19821799
39.

Coupled transcription-splicing regulation of mutually exclusive splicing events at the 5' exons of protein 4.1R gene.

Huang SC, Cho A, Norton S, Liu ES, Park J, Zhou A, Munagala ID, Ou AC, Yang G, Wickrema A, Tang TK, Benz EJ Jr.

Blood. 2009 Nov 5;114(19):4233-42. doi: 10.1182/blood-2009-02-206219. Epub 2009 Sep 3.

40.

Stage-specific susceptibility of human erythroblasts to Plasmodium falciparum malaria infection.

Tamez PA, Liu H, Fernandez-Pol S, Haldar K, Wickrema A.

Blood. 2009 Oct 22;114(17):3652-5. doi: 10.1182/blood-2009-07-231894. Epub 2009 Aug 25.

41.

High levels of tRNA abundance and alteration of tRNA charging by bortezomib in multiple myeloma.

Zhou Y, Goodenbour JM, Godley LA, Wickrema A, Pan T.

Biochem Biophys Res Commun. 2009 Jul 24;385(2):160-4. doi: 10.1016/j.bbrc.2009.05.031. Epub 2009 May 19.

42.

Loss of specific chaperones involved in membrane glycoprotein biosynthesis during the maturation of human erythroid progenitor cells.

Patterson ST, Li J, Kang JA, Wickrema A, Williams DB, Reithmeier RA.

J Biol Chem. 2009 May 22;284(21):14547-57. doi: 10.1074/jbc.M809076200. Epub 2009 Mar 3.

43.

Activation of protein kinase C{eta} by type I interferons.

Redig AJ, Sassano A, Majchrzak-Kita B, Katsoulidis E, Liu H, Altman JK, Fish EN, Wickrema A, Platanias LC.

J Biol Chem. 2009 Apr 17;284(16):10301-14. doi: 10.1074/jbc.M807254200. Epub 2009 Feb 11.

44.

Alternative pre-mRNA splicing switches modulate gene expression in late erythropoiesis.

Yamamoto ML, Clark TA, Gee SL, Kang JA, Schweitzer AC, Wickrema A, Conboy JG.

Blood. 2009 Apr 2;113(14):3363-70. doi: 10.1182/blood-2008-05-160325. Epub 2009 Feb 4.

45.

Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.

Artz AS, Wickrema A, Dinner S, Godley LA, Kocherginsky M, Odenike O, Rich ES, Stock W, Ulaszek J, Larson RA, van Besien K.

Biol Blood Marrow Transplant. 2008 Nov;14(11):1209-16. doi: 10.1016/j.bbmt.2008.08.004.

46.

Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3.

Zhou Y, Uddin S, Zimmerman T, Kang JA, Ulaszek J, Wickrema A.

Leuk Lymphoma. 2008 Oct;49(10):1945-53. doi: 10.1080/10428190802304966.

47.

Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.

Zhou L, Nguyen AN, Sohal D, Ying Ma J, Pahanish P, Gundabolu K, Hayman J, Chubak A, Mo Y, Bhagat TD, Das B, Kapoun AM, Navas TA, Parmar S, Kambhampati S, Pellagatti A, Braunchweig I, Zhang Y, Wickrema A, Medicherla S, Boultwood J, Platanias LC, Higgins LS, List AF, Bitzer M, Verma A.

Blood. 2008 Oct 15;112(8):3434-43. doi: 10.1182/blood-2008-02-139824. Epub 2008 May 12.

48.

Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.

Gordon MK, Sher D, Karrison T, Kebriaei P, Chuang K, Zhang Y, McDonnell D, Artz A, Godley L, Odenike O, Rich E, Michaelis L, Thirman MJ, Wickrema A, van Besien K, Larson RA, Stock W.

Leuk Lymphoma. 2008 Mar;49(3):531-7. doi: 10.1080/10428190701799043.

PMID:
18297531
49.

Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts.

Kang JA, Zhou Y, Weis TL, Liu H, Ulaszek J, Satgurunathan N, Zhou L, van Besien K, Crispino J, Verma A, Low PS, Wickrema A.

J Biol Chem. 2008 Mar 14;283(11):6997-7006. doi: 10.1074/jbc.M706712200. Epub 2008 Jan 3.

50.

Erythroid and megakaryocytic transformation.

Wickrema A, Crispino JD.

Oncogene. 2007 Oct 15;26(47):6803-15. Review.

PMID:
17934487

Supplemental Content

Loading ...
Support Center